Serum/plasma stability evidence — ADMETatlas
Skip to content
ADMET
atlas
peptide evidence atlas
Search peptide, product, endpoint, sequence…
K
Home
Browse
Developability
Resources
About
Search atlas
K
Home
Browse
Evidence
·
Metabolic & Proteolytic Stability
Reported
Serum/plasma stability evidence
ATLXM0000731
Home
Evidence
Peptides
Products
Evidence
Context signals
Descriptors
Developability
Profile
Comparator
Resources
Manual
Explanations
Statistics
Download
License
About
Serum/plasma stability
Measurement
ATLXM0000731
Peptide
ATLPC0023033
→
Measured material
Specific molecular form
Endpoint
Serum/plasma stability
→
ADMET domain
Metabolic & Proteolytic Stability
Value
Observation
Degradation occured initially after 10 min
Evidence role
Reported: reviewed reported observation that should not be pooled as a comparable value yet
Assay / model
HPLC · human · Human serum
Condition
Dose/window: 128, 64, 32, 16, 8, 4, 2, 1, and 0.5 μM · Human serum protease · In Vitro
Scientific source
DOI: 10.3390/ijms21165632
Source: PEPlife2
Open DOI
Manual
Explanations
Statistics
Download
About
Stack
© 2026 ADMETatlas, an academic peptide ADMET evidence atlas.
